How important is adherence when beginning antiretroviral therapy?
Internal medicine and emergency medicine physicians fail to offer HIV testing at sufficient levels.
With the continuous increasing epidemic of multidrug-resistant TB, new drugs and vaccines are urgently needed.
During these hard economic times when unemployment is at an all-time high, a nursing career offers thousands of jobs all over the world. But is a nursing career an option for an HIV-positive person? The answer to that question is yes.
Type 1 diabetes is an autoimmune disease, but how well do patients with T1DM respond to treatment with antibodies - and when should they be introduced?
HIV is a difficult virus to treat and no vaccine has been developed. One approach is to combine two or three treatments to form a cocktail of drugs that have a greater chance of slowing the spread of HIV around the body and the subsequent deterioration of the patient. This is known as highly active
Correlates of co-receptor tropism were investigated in a population of highly-treatment experienced patients.
Drs. Douglas Shaffer and Eunice Obiero highlight some of the key lessons learned from their experience with an integrated HIV/TB clinic in Kenya.
Work continues on finding the elusive HIV vaccine. But much work still needs to be done before such an HIV vaccine is ready for use. This is an update of several of the HIV vaccine studies being conducted at this time.
This article examines the pharmacokinetics of antiretrovirals in older HIV-infected patients.
What are the patient risk factors for failure to follow-up in HIV care?
Paul E. Sax, MD provides a review of a highly anticipated study at AIDS 2010. Learn about the efficacy and tolerability of the investigational NNRT rilpivirine (TMC-278) as compared with efavirenz.
A collection of HIV AIDS related terms beginning with the letter D
If you or someone close to you has AIDS, there are medical treatments that are surely being sought to slow the progress of the disease and address the health issues that come as a result of infection. There are other, alternative remedies that those who have AIDS use to better their quality of life.
Despite recommendations for routine HIV testing in health care settings, many remain untested.
In addition to new drug development, this author argues that a comprehensive strategy is needed to address this growing problem.
It's now common knowledge that the human immunodeficiency virus, also known as HIV, is the pathogen responsible for AIDS. Passed through infected bodily fluid, the virus weakens a person's immune system until the body is unable to properly defend itself. For some people, they can begin developing sy